Medical Communications
Eppendorf Award for Young European Investigators 2025 awarded to neuroscientist Varun Venkataramani
July 10, 2025 Medical Communications, Medical/ Scientific Writing, Research and Development Neurology, Oncology
First malaria medicine for infants under 4.5kg receives approval
July 9, 2025 Medical Communications, Research and Development Coartem Baby, Infections and infestations, Medicines for Malaria Venture, Novartis, Paediatrics, Swissmedic, malaria
Duke Street Bio receives FDA fast track designation for brain metastases treatment
July 8, 2025 Medical Communications, Research and Development Duke Street Bio, Oncology, US Food and Drug Administration, brain metastases, breast cancer, fast track designation
SMC recommends Eladynos for postmenopausal osteoporosis in Scotland
July 8, 2025 Medical Communications, Research and Development Musculo-skeletal disorder, NHS, Scottish Medicine Consortium, Theramex, clinical trials, osteoporosis, postmenopause
Purpose and people: the enduring power of brand and the evolution of employer identity
July 7, 2025 Branding, Business Services, Corporate Branding, Medical Communications, Sales and Marketing AstraZeneca, Identity, Inclusion, The Caffeine Partnership, benenden health, branding
Five facts about UV exposure and sun safety
July 7, 2025 Medical Communications Dermatology, Five Facts, Oncology, Skin, melanoma, skincare
FDA grants accelerated approval for advanced non-small cell lung cancer treatment
July 4, 2025 Medical Communications, Research and Development Breakthrough Therapy Designation, Oncology, US Food and Drug Administration, Zegfrovy, clinical trial, non-small cell lung cancer, priority review
Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatment
July 4, 2025 Medical Communications, Research and Development European Medicines Agency, Genito-Urinary system, Johnson & Johnson, Oncology, clinical trial, prostate cancer
Biocon Biologics gains EU approval for bone health therapies
July 4, 2025 Market Access, Medical Communications, Research and Development Biocon Biologics, Committee for Medicinal Products for Human USE, European Commission, Evfraxy, Oncology, Orthopaedics, Osteoporosis, Vevzuo, bone health, osteoporosis, prostate cancer
Carthera receives EMA endorsement for orphan medical device status of SonoCloud
July 2, 2025 Medical Communications, Research and Development Brain disorders, Breakthough Device Designation, CE marking, Carthera, Devices, European Medicines Agency (EMA), Food and Drug Administration, Forfait Innovation Status, Neurology, Orphan Medical Device Status, ultrasound imaging
SphingoTec’s PenKid leads the way in early detection of delayed graft function after kidney transplant
July 1, 2025 Medical Communications, Research and Development Nephrology, PenKid, SphingoTec, biomarker, clinical trial, delayed graft function, kidney replacement therapy, kidney transplant, serum creatinine
PharmNovo submits CTA for non-addictive neuropathic pain therapeutic
July 1, 2025 Medical Communications, Research and Development Clinical Trial Application (CTA), Neurology, Pain, PharmNovo, chronic cough, clinical trials, migraine, neuropathic pain, opioid use disorder, opioid withdrawal syndrome
FDA approves Gamifant for macrophage activation syndrome in Still’s disease
June 30, 2025 Medical Communications, Research and Development FDA, Immunology, Still's disease, gamifant, hemophagocytic lymphohistiocytosis, sobi
Inizio Evoke appoints Kelly Cusumano to drive strategic growth and innovation
June 27, 2025 Business Services, Marketing Consultancies, Medical Communications Corporate, Evoke Comms, Inizio Evoke, business strategist, executive vice president, marketing and communications
PMGroup/Visions4Health unveil Excellence in Healthcare Partnerships Awards
June 26, 2025 Medical Communications CHASE, Corporate, Excellence in Healthcare Partnerships Awards, NHS ConfedExpo, PMGroup, Visions4Health
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
